Search Results - "Yutaka HATTORI"
-
1
A thermoresponsive cationic block copolymer brush-grafted silica bead interface for temperature-modulated separation of adipose-derived stem cells
Published in Colloids and surfaces, B, Biointerfaces (01-12-2022)“…Adipose-derived mesenchymal stem cells (ADSCs) have beneficial effects in cell transplantation therapy; these cells are collected from adipose tissue using…”
Get full text
Journal Article -
2
Integrin β5 and β7 expression in lenalidomide-resistant multiple myeloma cells
Published in International journal of hematology (01-04-2022)Get full text
Journal Article -
3
Antibody drug separation using thermoresponsive anionic polymer brush modified beads with optimised electrostatic and hydrophobic interactions
Published in Scientific reports (27-07-2020)“…Antibody drugs play an important role in biopharmaceuticals, because of the specificity for target biomolecules and reduction of side effects. Thus, separation…”
Get full text
Journal Article -
4
Temperature-modulated cell-separation column using temperature-responsive cationic copolymer hydrogel-modified silica beads
Published in Colloids and surfaces, B, Biointerfaces (01-06-2019)“…[Display omitted] •A thermoresponsive-cationic beads packed column was developed.•Retention and elution of cells was modulated by changing temperature.•Cell…”
Get full text
Journal Article -
5
Dietary Supplementation with Sodium Butyrate Reduces High-sucrose Diet-induced Hepatic Accumulation of Triacylglycerols and Expression of Fatty Acid Synthesis Enzymes in Rats
Published in Journal of Oleo Science (01-01-2022)“…We investigated the effects of dietary supplementation with sodium butyrate (NaB) on the lipid levels, gene expression, and proteins related to lipid…”
Get full text
Journal Article -
6
Immunomodulatory Effect of Proteasome Inhibitors via the Induction of Immunogenic Cell Death in Myeloma Cells
Published in Pharmaceuticals (Basel, Switzerland) (27-09-2023)“…Several anti-cancer drugs are known to have immunomodulatory effects, including immunogenic cell death (ICD) of cancer cells. ICD is a form of apoptosis which…”
Get full text
Journal Article -
7
SORT1/LAMP2-mediated extracellular vesicle secretion and cell adhesion are linked to lenalidomide resistance in multiple myeloma
Published in Blood advances (26-04-2022)“…Multiple myeloma (MM) is a hematopoietic malignancy whose prognosis has improved with the development of new agents such as lenalidomide over the last decade…”
Get full text
Journal Article -
8
Negative E-cadherin expression on bone marrow myeloma cell membranes is associated with extramedullary disease [version 1; peer review: 2 approved]
Published in F1000 research (2022)“…Background: The loss of E-cadherin expression and the induction of N-cadherin are known as hallmarks of the epithelial-to-mesenchymal transition, an essential…”
Get full text
Journal Article -
9
A novel derivative (GTN024) from a natural product, komaroviquinone, induced the apoptosis of high-risk myeloma cells via reactive oxygen production and ER stress
Published in Biochemical and biophysical research communications (02-11-2018)“…New drugs have significantly improved the survival of patients with multiple myeloma (MM), but the prognosis of MM patients with high-risk cytogenetic changes…”
Get full text
Journal Article -
10
Characteristics of a Novel Target Antigen against Myeloma Cells for Immunotherapy
Published in Vaccines (Basel) (02-10-2020)“…Despite the availability of therapeutic treatments, multiple myeloma is an incurable haematological disorder. In this study, we aimed to clarify the role of…”
Get full text
Journal Article -
11
GTN057, a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c‐MET tyrosine kinase
Published in Cancer medicine (Malden, MA) (01-04-2023)“…Objective Despite the development of newly developed drugs, most multiple myeloma (MM) patients with high‐risk cytogenetic abnormalities such as t(4;14) or…”
Get full text
Journal Article -
12
Synthesis and biological evaluation of the natural product komaroviquinone and related compounds aiming at a potential therapeutic lead compound for high-risk multiple myeloma
Published in Bioorganic & medicinal chemistry letters (01-10-2017)“…[Display omitted] Alternatives of treatments for multiple myeloma (MM) have become increasingly available with the advent of new drugs such as proteasome…”
Get full text
Journal Article -
13
Identification of Novel HLA-A24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies
Published in PloS one (19-01-2016)“…The homeobox protein, PEPP2 (RHOXF2), has been suggested as a cancer/testis (CT) antigen based on its expression pattern. However, the peptide epitope of PEPP2…”
Get full text
Journal Article -
14
Negative E-cadherin expression on bone marrow myeloma cell membranes is associated with extramedullary disease [version 2; peer review: 2 approved]
Published in F1000 research (2022)“…Background: The loss of E-cadherin expression and the induction of N-cadherin are known as hallmarks of the epithelial-to-mesenchymal transition, an essential…”
Get full text
Journal Article -
15
Dietary Supplementation with Sodium Butyrate Reduces High-sucrose Diet-induced Hepatic Accumulation of Triacylglycerols and Expression of Fatty Acid Synthesis Enzymes in Rats
Published in Journal of Oleo Science (01-08-2022)“…[Abstract] : We investigated the effects of dietary supplementation with sodium butyrate (NaB) on the lipid levels, gene expression, and proteins related to…”
Get full text
Journal Article -
16
A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts
Published in PloS one (24-01-2015)“…Despite the recent advances in the treatment of multiple myeloma (MM), MM patients with high-risk cytogenetic changes such as t(4;14) translocation or deletion…”
Get full text
Journal Article -
17
A phthalimide derivative that inhibits centrosomal clustering is effective on multiple myeloma
Published in PloS one (25-06-2012)“…Despite the introduction of newly developed drugs such as lenalidomide and bortezomib, patients with multiple myeloma are still difficult to treat and have a…”
Get full text
Journal Article -
18
An anilinoquinazoline derivative inhibits tumor growth through interaction with hCAP-G2, a subunit of condensin II
Published in PloS one (13-09-2012)“…We screened 46 novel anilinoquinazoline derivatives for activity to inhibit proliferation of a panel of human cancer cell lines. Among them, Q15 showed potent…”
Get full text
Journal Article -
19
Single‐institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma: Prognostic factors and unique toxicity profile
Published in Cancer science (01-06-2008)“…We previously reported a pilot study of thalidomide monotherapy for Japanese patients with refractory or relapsed multiple myeloma. In the present work, we…”
Get full text
Journal Article -
20
NK4, an antagonist of hepatocyte growth factor (HGF), inhibits growth of multiple myeloma cells: molecular targeting of angiogenic growth factor
Published in Blood (01-04-2007)“…Hepatocyte growth factor (HGF) promotes cell growth and motility and also increases neovascularization. Multiple myeloma (MM) cells produce HGF, and the plasma…”
Get full text
Journal Article